2965 studies found for:    Head and Neck Neoplasms [ CONDITION ] OR Mouth Neoplasms [ CONDITION ]
Show Display Options
Rank Status Study
1 Active, not recruiting Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
Conditions: Mouth Neoplasms;   Head and Neck Neoplasms;   Tongue Neoplasms;   Carcinoma, Squamous Cell
Intervention: Drug: Sirolimus
2 Recruiting Patient Evaluation for Head and Neck Surgery Branch Studies
Conditions: Head and Neck Neoplasms;   Pharyngeal Cancer;   Oral Cancer;   Carcinoma, Squamous Cell;   Laryngeal Cancer
Intervention:
3 Recruiting Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Neoplasms;   Laryngeal Neoplasms;   Mouth Neoplasms;   Pharyngeal Neoplasms
Interventions: Drug: cetuximab (associated with radiotherapy);   Drug: cisplatin (associated to radiotherapy)
4 Withdrawn ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer
Conditions: Lip and Oral Cavity Cancer;   Head and Neck Cancer;   Oropharyngeal Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: ONYX-015
5 Terminated Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer
Conditions: Advanced Squamous Cell Carcinoma of the Head and Neck;   Carcinoma, Squamous Cell;   Neoplasms, Squamous Cell;   Head and Neck Neoplasms;   Mouth Neoplasms;   Head and Neck Cancer
Intervention: Drug: Proxinium
6 Terminated Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer
Conditions: Recurrent Squamous Cell Carcinoma of the Head and Neck;   Carcinoma, Squamous Cell;   Neoplasms, Squamous Cell;   Head and Neck Neoplasms;   Mouth Neoplasms;   Head and Neck Cancer
Intervention: Drug: Proxinium
7 Completed Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer
Conditions: Carcinoma, Squamous;   Head and Neck Cancer;   Oral Cancer;   Laryngeal Cancer;   Pharyngeal Cancer
Interventions: Drug: Bortezomib (Velcade, PS-341);   Drug: Cetuximab;   Drug: Cisplatin;   Procedure: Radiation Therapy
8 Active, not recruiting Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma
Conditions: Head and Neck Cancer;   Oral Cavity Cancer;   Oropharyngeal Cancer
Intervention: Drug: Valproic Acid
9 Active, not recruiting F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients
Conditions: Mouth Neoplasms;   Oropharyngeal Neoplasms;   Laryngeal Neoplasms;   Head and Neck Neoplasms
Intervention: Drug: F-18 Fluorothymidine
10 Recruiting Oral Cancer Adjuvant Therapy (OCAT) Trial
Condition: Mouth Neoplasms
Intervention: Procedure: Post-operative chemoradiotherapy / accelerated radiotherapy
11 Completed A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
Conditions: Mouth Cancer;   Lip Cancer;   Throat Cancer;   Lip Neoplasms;   Head and Neck Cancers
Intervention:
12 Completed Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors
Conditions: Liver Metastasis;   Pelvic Cancer;   Head and Neck Cancer;   Sarcoma;   Rectal Cancer;   Breast Cancer;   Colorectal Cancer;   Mouth Cancer
Interventions: Drug: LS 11(Taporfin Sodium);   Device: Lumaflex Light Delivery Catheter
13 Active, not recruiting IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC
Conditions: Oral Cancer;   Oropharynx Cancer;   Hypopharynx Cancer
Interventions: Procedure: IMRT 75 Gy;   Procedure: Conventional radiotherapy 70 Gy;   Drug: concomitant cisplatin
14 Active, not recruiting Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
Conditions: Locally Advanced Malignant Neoplasm;   Oral Cancer;   Oropharyngeal Carcinoma
Intervention: Drug: Neo-adjuvant Erbitux-based chemotherapy
15 Recruiting Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
Conditions: Locally Advanced Malignant Neoplasm;   Oral Cancer;   Oropharyngeal Carcinoma;   Effects of Chemotherapy
Intervention: Drug: Neo-adjuvant Erbitux-based chemotherapy
16 Active, not recruiting Erlotinib Prevention of Oral Cancer (EPOC)
Condition: Oral Cancer
Interventions: Drug: Erlotinib;   Drug: Placebo
17 Unknown  Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions
Condition: Oral Cancer
Intervention:
18 Recruiting Study on the Carcinogenesis of Gα12 in Oral Cancer, and the Treatment of Oral Cancer Using Ga12 Inhibitor.
Conditions: Carcinogenesis;   Oral Cancer
Intervention:
19 Recruiting Study on the Carcinogenesis of SOX-9 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer.
Conditions: Carcinogenesis;   Oral Cancer
Intervention:
20 Not yet recruiting GDF15 Based TPF Induction Chemotherapy for OSCC Patients
Conditions: Mouth Neoplasms;   Carcinoma, Squamous Cell
Interventions: Drug: TPF induction chemotherapy;   Procedure: surgery group;   Radiation: Post-operative radiotherapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years